NDC 72162-2194-01 - Carbidopa and Levodopa
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-2194
- Requested NDC
- 72162-2194-01
- Package NDCs from labels
- 72162-2194-1, 72162-2194-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2026-07-16
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Carbidopa and Levodopa - Bryant Ranch Prepack | Bryant Ranch Prepack | 2026-07-16 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2194-1 | Carbidopa and Levodopa | 100 in 1 BOTTLE | TABLET, EXTENDED RELEASE | 100 | 102 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-2194 | CARBIDOPA AND LEVODOPA TABLET, EXTENDED RELEASE [BRYANT RANCH PREPACK] | 101 | Current NDC, 1 package rows | 20231219_043e58c6-092d-4637-90f1-9d36af143a24.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2194-1 | EA - Each | 72162-2194 | d2489d37-8e43-4def-87db-10341bc9cb10 | 1 | 2024-01-04 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| CREXONT | CARBIDOPA AND LEVODOPA | Amneal Pharmaceuticals LLC | 095a08b6-b0b8-4f88-b759-67e8b87287a0 | 2026-05-29 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Major Pharmaceuticals | 3f6d393e-ac84-4a3c-a837-199d1ec71fd2 | 2026-05-28 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Westminster Pharmaceuticals, LLC | 3f026272-32a6-4c98-8b6f-d910c7f58aa2 | 2026-05-27 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Dr. Reddy's Laboratories Inc | 87ab55c9-203d-d595-3e3e-0e38f2f6d9c4 | 2026-05-19 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and levodopa | CARBIDOPA AND LEVODOPA | Advagen Pharma Ltd | 5b6519ff-d1af-402b-83eb-b4fce6743a18 | 2026-05-12 | Warnings, Adverse reactions | 308988 308989 MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | 4ce99f65-5857-448c-b22a-9b3b64de69e2 | 2026-04-29 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | ScieGen Pharmaceuticals Inc | a32afa84-7bc0-4bd3-bc50-55d738f3d7ce | 2026-04-27 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Mylan Pharmaceuticals Inc. | aa5028d6-fd0a-4cf1-b708-c93bb2a7c76a | 2026-04-24 | Warnings, Adverse reactions | 308988 308989 MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | b29e58f0-67b1-4036-a4a8-4915a8c13cdf | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | beedd327-bbc5-4f17-838a-4e72bf0867f0 | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | 57688b2c-7be0-4e73-9b4f-7ec3b5dc1c37 | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | REMEDYREPACK INC. | 9ac804f1-7e15-48bc-8ae9-25181a629dd4 | 2026-04-24 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| CARBIDOPA AND LEVODOPA | CARBIDOPA AND LEVODOPA | Coupler LLC | 500f0cdb-10e1-9545-e063-6394a90a3ad1 | 2026-04-22 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Cardinal Health 107, LLC | 19d853e2-b8bd-490e-b8d2-b38bec68a139 | 2026-04-16 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Exovisse Preservative-Free Artificial Tears | LUBRICANT EYE GEL DROPS | YD BIO USA, INC. | 4f20191a-9124-2525-e063-6294a90a8428 | 2026-04-10 | Warnings | 3NXW29V3WO |
| Carbidopa and Levodopa | CARBIDOPA AND LEVODOPA | Aurobindo Pharma Limited | 4ced8a05-27ac-463f-b331-387e473fdaa1 | 2026-04-09 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| CARBIDOPA, LEVODOPA AND ENTACAPONE | CARBIDOPA, LEVODOPA AND ENTACAPONE | Rising Pharma Holdings, Inc. | 2f8e82d7-6baf-456a-b8c3-4fda6e317902 | 2026-04-08 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| Carbidopa, Levodopa and Entacapone | CARBIDOPA, LEVODOPA AND ENTACAPONE | Macleods Pharmaceuticals Limited | f0d9d7a8-1d06-4119-b2bc-42b3ec08d45b | 2026-04-08 | Warnings, Adverse reactions | MNX7R8C5VO 46627O600J |
| LensMate Preservative-Free Artificial Tears | LUBRICANT EYE DROPS | YD BIO USA, INC. | 4ebacb2b-9b2d-6bc1-e063-6294a90a3426 | 2026-04-05 | Warnings | 3NXW29V3WO |
| Exovisse Preservative-Free Artificial Tears | LUBRICANT EYE GEL DROPS | YD BIO USA, INC. | 4ebc154b-128b-9dde-e063-6294a90ae00e | 2026-04-05 | Warnings | 3NXW29V3WO |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.